These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1509 related items for PubMed ID: 19142573

  • 21. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L, BoTULS investigators.
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [Abstract] [Full Text] [Related]

  • 22. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity.
    Demetrios M, Khan F, Turner-Stokes L, Brand C, McSweeney S.
    Cochrane Database Syst Rev; 2013 Jun 05; (6):CD009689. PubMed ID: 23740539
    [Abstract] [Full Text] [Related]

  • 23. Effects of botulinum toxin injections in the upper limbs of children with cerebral palsy: A systematic review of the literature.
    Klein C, Gouron R, Barbier V.
    Orthop Traumatol Surg Res; 2024 May 05; 110(3):103578. PubMed ID: 36754169
    [Abstract] [Full Text] [Related]

  • 24. Botulinum neurotoxin type A responders among children with spastic cerebral palsy: Pattern-specific effects.
    Papageorgiou E, Peeters N, Staut L, Molenaers G, Ortibus E, Van Campenhout A, Desloovere K.
    Eur J Paediatr Neurol; 2024 Mar 05; 49():131-140. PubMed ID: 38518417
    [Abstract] [Full Text] [Related]

  • 25. Immunogenicity induced by botulinum toxin injections for limb spasticity: A systematic review.
    Mathevon L, Declemy A, Laffont I, Perennou D.
    Ann Phys Rehabil Med; 2019 Jul 05; 62(4):241-251. PubMed ID: 30980953
    [Abstract] [Full Text] [Related]

  • 26. A randomized trial of upper limb botulimun toxin versus placebo injection, combined with physiotherapy, in children with hemiplegia.
    Ferrari A, Maoret AR, Muzzini S, Alboresi S, Lombardi F, Sgandurra G, Paolicelli PB, Sicola E, Cioni G.
    Res Dev Disabil; 2014 Oct 05; 35(10):2505-13. PubMed ID: 24995688
    [Abstract] [Full Text] [Related]

  • 27. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF, Fu CP, Kao NT, Chan RC, Chen SJ.
    Am J Phys Med Rehabil; 2003 Apr 05; 82(4):284-9. PubMed ID: 12649654
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The utility of shear wave elastography in the evaluation of muscle stiffness in patients with cerebral palsy after botulinum toxin A injection.
    Dağ N, Cerit MN, Şendur HN, Zinnuroğlu M, Muşmal BN, Cindil E, Oktar SÖ.
    J Med Ultrason (2001); 2020 Oct 05; 47(4):609-615. PubMed ID: 32705628
    [Abstract] [Full Text] [Related]

  • 30. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R, Akturk S, Ersoy Y.
    Eur J Phys Rehabil Med; 2018 Oct 05; 54(5):738-744. PubMed ID: 29422486
    [Abstract] [Full Text] [Related]

  • 31. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
    Rosales RL, Kong KH, Goh KJ, Kumthornthip W, Mok VC, Delgado-De Los Santos MM, Chua KS, Abdullah SJ, Zakine B, Maisonobe P, Magis A, Wong KS.
    Neurorehabil Neural Repair; 2012 Sep 05; 26(7):812-21. PubMed ID: 22371239
    [Abstract] [Full Text] [Related]

  • 32. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J, Entner T.
    Wien Klin Wochenschr; 2001 Sep 05; 113 Suppl 4():20-4. PubMed ID: 15506048
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
    Madsen ES, Sonne-Holm S, Wong C, Curtis D, Bencke J.
    Ugeskr Laeger; 2015 Jan 12; 177(3):V07140409. PubMed ID: 25613095
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
    Carraro E, Trevisi E, Martinuzzi A.
    Eur J Paediatr Neurol; 2016 Jul 12; 20(4):532-7. PubMed ID: 27177451
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.
    Sheean G.
    Drug Saf; 2006 Jul 12; 29(1):31-48. PubMed ID: 16454533
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 76.